Email this article 
Vitamin D Associated Peculiarities in Women with Mild Covid-19 and Effect of Calcifediol on the Level of Vitamin D and Possibly, on Disease Outcome - Prospective Pilot Study
Abstract
Presented study provides information about prospective pilot study concerning the vitamin D in women with mild COVID-19 (SARSCoV2) and effect of Calcifediol on the vitamin D level and possibly, on disease outcome.
The study involved 30 women aged 48 to 72 years who were treated for a mild form of new coronavirus infection between 1.09.2020 - 1.12.2020 at the First University Clinic of TSMU.
In all patients, the new type SARSCoV2 was confirmed by polymerase chain reaction performed with reagents-Xpert Xpress SARS-CoV-2 (Cepheid, USA) on GeneXpert (USA) analyzer (closed system). D-dimer, ferritin, C-reactive protein and lactate dehydrogenase were detected upon the hospital admission. Vitamin D was defined using Roche reagents (electrochemiluminescence method; Roche HITACHICobase-411 device- Switzerland).
On the 1st day of hospital admission, all patients received 0.266 mg (1 capsule) of calcifediol (16000 UI) in the form of the drug Hydroferol (FAES FARMA, S.A., Spain). Vitamin D and -reactive protein was defined repeatedly on the 5th day of treatment.
Results: Studies have shown that on the 5th day after hydroferol administration the vitamin D level in patients with COVID-19 was significantly increased [16.8 (12.2–24.2) vs. 56.4 (52.3–62.2), p<0.0001]. Negative relationship was found between the onset of symptoms and baseline vitamin D levels (F = 5.9223, p <0.026). The negative relationship was found between the repeatedly defined levels of vitamin D and C-reactive protein (F=12.82, p<0.009) also, pointing on the positive treatment effect of vitamin D on the course of mild form of Covid-19. None of the patients required continued treatment in the intensive care unit and were discharged home with satisfactory state.
Conclusion: Vitamin D supposedly plays the important role in pathogenesis and outcome of SARSCoV2 virus infected patients. Additional large-scale randomized placebo-controlled studies on the role of vitamin D in COVID-19 pathogenesis are needed.
Keywords
Full Text:
PDFReferences
Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Reviews in Endocrine and Metabolic Disorders2017. pp 153–165. . (doi:10.1007/s11154-017-9424-1);
Holick MF & Chen TC. Vitamin D deficiency: A worldwide problem with health consequences. American Journal of Clinical Nutrition 2008 87 . (doi:10.1093/ajcn/87.4.1080s);
Fuss CT & Fassnacht M. Vitamin D – Ein kritischer Blick auf die Studienlage Die vermeintlich pleiotrope Wirkung von Vitamin D. 2020 . Article in German;
Bouillon R, Marcocci C, Carmeliet G, Bikle D, White JH, Dawson-Hughes B, Lips P, Munns CF, Lazaretti-Castro M, Giustina A, & Bilezikian J. Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions. Endocrine Reviews2019. pp 1109–1151. . (doi:10.1210/er.2018-00126);
Keum N, Lee DH, Greenwood DC, Manson JE, & Giovannucci E. Vitamin D supplementation and total cancer incidence and mortality: A meta-Analysis of randomized controlled trials. Annals of Oncology2019. pp 733–743. . (doi:10.1093/annonc/mdz059);
Haykal T, Samji V, Zayed Y, Gakhal I, Dhillon H, Kheiri B, Kerbage J, Veerapaneni V, Obeid M, Danish R, & Bachuwa G. The role of vitamin D supplementation for primary prevention of cancer: meta-analysis of randomized controlled trials. Journal of Community Hospital Internal Medicine Perspectives 2019 9 480–488. (doi:10.1080/20009666.2019.1701839);
Issa CM. Vitamin D and Type 2 Diabetes Mellitus. In Advances in experimental medicine and biology, pp 193–205. Adv Exp Med Biol,2017;
Grau M V., Baron JA, Sandler RS, Hail RW, Beach ML, Church TR, & Heber D. Vitamin D, calcium supplementation, and colorectal adenomas: Results of a randomized trial. Journal of the National Cancer Institute 2003 95 1765–1771. (doi:10.1093/jnci/djg110);
Grammatiki M, Rapti E, Karras S, Ajjan RA, & Kotsa K. Vitamin D and diabetes mellitus: Causal or casual association? Reviews in Endocrine and Metabolic Disorders2017. pp 227–241. . (doi:10.1007/s11154-016-9403-y);
Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, Goodall EC, Grant CC, Griffiths CJ, Janssens W, Laaksi I, Manaseki-Holland S, Mauger D, Murdoch DR, Neale R, Rees JR, Simpson S, Stelmach I, Kumar GT, Urashima M, & Camargo CA. Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data. BMJ (Online) 2017 356 . (doi:10.1136/bmj.i6583);
Zhou YF, Luo BA, Qin LL, & Shidoji Y. The association between Vitamin D deficiency and community-acquired pneumonia: A meta-analysis of observational studies. Medicine (United States) 2019 98 . (doi:10.1097/MD.0000000000017252);
Gombart AF, Pierre A, & Maggini S. A review of micronutrients and the immune system–working in harmony to reduce the risk of infection. Nutrients 2020 12 . (doi:10.3390/nu12010236);
Gruber-Bzura BM. Vitamin D and influenza—Prevention or therapy? International Journal of Molecular Sciences2018. (doi:10.3390/ijms19082419);
Ilie PC, Stefanescu S, & Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clinical and Experimental Research 2020 32 1195–1198. (doi:10.1007/s40520-020-01570-8);
Grant WB, Baggerly CA, & Lahore H. Reply: “vitamin d supplementation in influenza and covid-19 infections. comment on: Evidence that vitamin d supplementation could reduce risk of influenza and covid-19 infections and deaths nutrients 2020, 12(4), 988”. Nutrients2020. (doi:10.3390/nu12061620);
Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, Alcalá Díaz JF, López Miranda J, Bouillon R, & Quesada Gomez JM. “Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”. Journal of Steroid Biochemistry and Molecular Biology 2020 203 105751. (doi:10.1016/j.jsbmb.2020.105751);
Merzon E, Tworowski D, Gorohovski A, Vinker S, Golan Cohen A, Green I, & Frenkel‐Morgenstern M. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study. The FEBS Journal 2020 287 3693–3702. (doi:10.1111/febs.15495);
Annweiler C, Hanotte B, Grandin de l’Eprevier C, Sabatier JM, Lafaie L, & Célarier T. Vitamin D and survival in COVID-19 patients: A quasi-experimental study. Journal of Steroid Biochemistry and Molecular Biology 2020 204 105771. (doi:10.1016/j.jsbmb.2020.105771);
Dietrich PDJW. Schützt Vitamin D vor schwerem COVID-19? Ein Endokrinologe erklärt die Datenlage und ob eine Supplementierung sinnvoll ist. https://deutsch.medscape.com/artikelansicht/49096632021. Article in German;
Pham H, Waterhouse M, Baxter C, Duarte Romero B, McLeod DSA, Armstrong BK, Ebeling PR, English DR, Hartel G, Kimlin MG, Martineau AR, O’Connell R, Pols JC van der, Venn AJ, Webb PM, Whiteman DC, & Neale RE. The effect of vitamin D supplementation on acute respiratory tract infection in older Australian adults: an analysis of data from the D-Health Trial. The Lancet Diabetes and Endocrinology 2021 9 69–81. (doi:10.1016/S2213-8587(20)30380-6);
Appel LJ, Michos ED, Mitchell CM, Blackford AL, Sternberg AL, Miller ER, Juraschek SP, Schrack JA, Szanton SL, Charleston J, Minotti M, Baksh SN, Christenson RH, Coresh J, Drye LT, Guralnik JM, Kalyani RR, Plante TB, Shade DM, Roth DL, & Tonascia J. The Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults. Annals of Internal Medicine 2021 174 145–156. (doi:10.7326/m20-3812);
Overview | COVID-19 rapid guideline: vitamin D | Guidance | NICE;
Vitamin D for COVID-19 [A] Evidence reviews for the use of vitamin D supplementation as prevention and treatment of COVID-19 NICE guideline NG187. 2020;
Stellungnahme der Deutschen Gesellschaft für Endokrinologie zur Rolle von Vitamin D in der Corona-Pandemie - www.endokrinologie.net. Position in German;
DOI: http://dx.doi.org/10.52155/ijpsat.v27.2.3269
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Grigoryan Karen, Mikaberidze Khatia, Ratiani Levan, Goginashvili Nino, Pachkoria Elene, Gabunia Luiza, Sanikidze Tamar, Pkhaladze Maia, Metreveli Levan, Ghambashidze Ketevan
This work is licensed under a Creative Commons Attribution 4.0 International License.